Gene expression in the Andes; relevance to neurology at sea level

Journal of the Neurological Sciences

Volumn 207, Issue 1-2, 2003, Pages 37-41

  Appenzeller, Otto ^a   Minko, Tamara ^b   Pozharov, Vitaly ^c   Bonfichi, Maurizio ^d   Malcovati, Luca ^d   Gamboa, Jorge ^e   Bernardi, Luciano ^d  

^a New Mex Hlth Enhancement M   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c Orchid Cellmark   (United States)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Aging; Gene expression in Andeans; Human chronic hypoxia; Nervous system

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ADULT; AGE DISTRIBUTION; ALTITUDE ACCLIMATIZATION; BIRTH; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL ARTICLE; CONFERENCE PAPER; GENE EXPRESSION; GEOGRAPHIC DISTRIBUTION; HUMAN; MALE; MEDICAL ASSESSMENT; OXYGEN CONCENTRATION; PRIORITY JOURNAL; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SEA LEVEL;

ADULT; ALTITUDE; ALTITUDE SICKNESS; ANALYSIS OF VARIANCE; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PERU; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 12244312510     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00356-8     Document Type: Conference Paper

References (15)

1. West J.B. High altitude medicine and biology in North Chile. High Alt. Med. Biol. 1:2000;149-151.
2. Beal C.M. Tibetan and Andean contrasts in adaptation to high-altitude hypoxia. Adv. Exp. Med. Biol. 475:2000;63-74.
3. Leon-Velarde F. The diagnostic criteria for chronic mountain sickness. Presented at: The Third World Congress on Mountain Medicine and High Altitude Physiology, Matsumoto, Japan:1998;160-163.
4. Minko T., Kopeckova P., Pozharov V., Kopecek J. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J. Control. Release. 54:1998;223-233.
5. Lei J., Jiang A., Pei D. Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF183. Biochim. Biophys. Acta. 1443:1998;400-406.
6. Tischer E., Mitchell R., Hartman T.et al. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:1991;11947-11954.
7. Monge M.C. Sobre un caso de enfermedad de Váquez. 1925;1-7 Comunicatión presentada a la Academia Nacional de Medicina, Lima.
8. Silveira L.H., Martinez-Lavin M., Pineda C.et al. Vascular endothelial growth factor and hypertrophic osteoartropathy. Clin. Exp. Rheumatol. 18:2000;57-62.
9. Sime F., Monge C.C., Whittembury J. Age as a cause of chronic mountain sickness (Monge's disease). Int. J. Biometeorol. 19:1975;93-98.
10. Whittembury J., Monge C.C. High altitude, haematocrit and age. Nature. 238:1972;278-279.
11. Oosthuyse B., Moons L., Storkebaum E.et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28:2001;131-138.
12. Monge C.C. Medical research in the Andes. Ann. Sports Med. 4:1988;245-254.
13. Beall M.C., Laskowski D., Strohl K.P.et al. Pulmonary nitric oxide in mountain dwellers. Nature. 414:2001;411-412.
14. Hoffman M.A., Ohh M., Yang H.et al. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to down regulate HIF. Hum. Mol. Genet. 10:2001;1019-1027.
15. Heath D., Williams D.R. High-altitude medicine and pathology. 1989;85-86 Butterworth, London.